FDA webinar Oct. 31 on proposed rule for laboratory developed tests
On Oct. 31 at 1 p.m. ET, the Food and Drug Administration will host a webinar to review its recent proposed rule for laboratory developed tests, which would amend the agency’s regulations to require most laboratory developed tests to meet the same medical device requirements as other in vitro diagnostic products. Participants may email questions for consideration to CDRHWebinars@fda.hhs.gov until Oct. 23.
Related News Articles
Headline
The Cybersecurity and Infrastructure Security Agency and other federal agencies released a joint guide yesterday for organizations to apply zero…
Headline
The Centers for Medicare & Medicaid Services and the Food and Drug Administration April 23 announced a new pathway to expedite access to certain FDA-…
Headline
A new tactical brief on technology-enabled care explores key trends, innovations and learnings, and provides considerations for how hospitals can…
Headline
The Assistant Secretary for Technology Policy/Office of the National Coordinator for Health Information Technology released a request for information Jan. 29…
Headline
The Food and Drug Administration announced Dec. 5 that it will launch the Technology-Enabled Meaningful Patient Outcomes for Digital Health Devices Pilot, or…
Headline
The Health Sector Coordinating Council’s Cybersecurity Working Group Nov. 18 released a best practices guide for health care organizations and medical device…